Home
/
GeneDx Holdings Corp.
/
Financials
/
Quarterly
GeneDx Holdings Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GeneDx Holdings Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$116.74M
Oct 28, 2025
Q2
2025
Jun 30, 2025
$102.69M
Jul 29, 2025
Q1
2025
Mar 31, 2025
$87.12M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$76.87M
Oct 28, 2025
Q2
2025
Jun 30, 2024
$70.51M
Jul 29, 2025
Q1
2025
Mar 31, 2024
$62.42M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$53.30M
Oct 29, 2024
Q2
2024
Jun 30, 2023
$48.71M
Jul 30, 2024
Q1
2024
Mar 31, 2023
$43.14M
Apr 29, 2024
Q3
2023
Sep 30, 2022
$83.23M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$36.17M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$53.94M
May 9, 2023
Q3
2022
Sep 30, 2021
$43.18M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$47.02M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$64.20M
May 12, 2022
Q3
2021
Sep 30, 2020
$38.61M
Nov 15, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.64M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
$10.81M
Jul 29, 2025
Q1
2025
Mar 31, 2025
($6.53M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($8.31M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($29.17M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($20.24M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($42.29M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($46.72M)
Jul 30, 2024
Q1
2024
Mar 31, 2023
($60.99M)
Apr 29, 2024
Q3
2023
Sep 30, 2022
($77.58M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($85.74M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($76.90M)
May 9, 2023
Q3
2022
Sep 30, 2021
$32.73M
Nov 14, 2022
Q2
2022
Jun 30, 2021
($46.16M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($191.78M)
May 12, 2022
Q3
2020
Sep 30, 2020
($56.9K)
Nov 16, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.25M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
$8.96M
Jul 29, 2025
Q1
2025
Mar 31, 2025
($4.55M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($7.78M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($10.58M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($13.66M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($42.97M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($51.62M)
Jul 30, 2024
Q1
2024
Mar 31, 2023
($60.36M)
Apr 29, 2024
Q3
2023
Sep 30, 2022
($90.82M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($162.65M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($89.31M)
May 9, 2023
Q3
2022
Sep 30, 2021
($88.26M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($45.45M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($196.66M)
May 12, 2022
Q3
2020
Sep 30, 2020
($59.7K)
Nov 16, 2020